NCT04348292 2024-08-22
Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer
Emory University
Phase 1 Terminated
Emory University
National Institutes of Health Clinical Center (CC)
University of Chicago
University of Chicago
Jonsson Comprehensive Cancer Center